Navigation Links
CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting
Date:10/30/2009

on, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to publication of clinical results, clinical acceptance of products, and growing demand for treatments are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2009 fiscal year and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D.

'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
2. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
3. CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
4. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
5. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
6. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
7. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
8. FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics Focus Diagnostics
9. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
10. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
11. Health Reform Bills Still Lack Strategic Focus on Health Workforce

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, MammographyEquipment-AGlo...ker.com/p0164330/Mammography-Equipment---A-Global-...eastcancerinindustrializedaswellasdevelopingnation...hymarket.Globally,escalatingawarenessaboutbreastca...
(Date:11/25/2009)...,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accordi...yonmedicaltechnologymarketintelligence,thenearly$3...etoseerapidgrowthoverthenextfiveyearsdespitetherec...s 2010 reportfindsthatthismarketwillremainhighlyd...ingspecializeddevicesinpreviouslyunderservedsegmen...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, PainManagement-GlobalTren...ain-Management---Global-Trends.html ,, Widespr...ementclinics,andtheadventofnewdrugshaveaccelerated...ereformsandreimbursementstructurecontinuetoshapede...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference 13851 1NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 1NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 2HS 7 Document Regarding Research @ M D Anderson Orlando 4942 1
...NE, N.J., May 29 Bayer Healthcare Pharmaceuticals...ing the use of Leukine(R) (sargramostim) will be p...Oncology (ASCO) Annual Meeting. , , "We are exc...een accepted at ASCO," said Pam Cyrus, MD, vice pr...re Pharmaceuticals. , , Abstracts are now availab...
...argest Genomic Study Comparing Gene Expression in ...Meeting - , , ORLANDO, Fla., May 29 Genomic Heal... from a study which summarized the gene signatures...test in a large number of male patients for whom t...apy. The results, which will be presented in a pos...
Other Medicine Technology:Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting 2Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting 3Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5
(Date:11/25/2009)...RSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anartic...DrugEvaluationandResearch,titled"ADifficultBalance...Nov.26,2009issueofTheNewEnglandJournalofMedicine. ...0090824/FDALOGO ) ,, Inthearticle,Woodcockdiscu...edicationforthosewhoneeditandmanagingtherisksposed...
(Date:11/25/2009)...ANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMa... Spare the Air Alert forThursday,Novem...soranyothersolidfuel,bothindoorsandoutdoors. ,,...litytomorrow,"saidJackBroadbent,executiveofficerof...ctthehealthoftheirneighborsandfellowcommunitymembe...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)...low-up period was too short to draw definite concl.... 25 (HealthDay News) -- In diabetic patients with... difference in outcomes at one year whether patien...ting, British researchers report. , Bypass surg...atients with coronary artery disease. However, les...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ing the chances,of women faced with an aggressive ...nflammatory breast cancer spreads quickly and can ...rodeoxyglucose positron emission,tomography combin...day at the annual meeting of the Radiological Soci...
...rials Worldwide,Inc. announced today that their pe...uit, which is related to Datasci,s U.S. Patent Num...ion of clinical trial data. Under the,terms of the...e granted a license to etrials," said Dr. Marc,Koz...
...VEREST Pivotal Study and Begin ...nue to Build on Initial Data Showing Durability, E...or Percutaneous Repair of Mitr...lves,announced today that it had successfully comp...
...e agency looking into Tamiflu; Relenza also under ...News) -- A U.S. Food and Drug Administration panel...eling for the prescription flu drug Tamiflu (oselt...idering label changes to Tamiflu and another flu d...
...You Measuring the Wrong Things?, NEW YORK and LON... ensure maximum return on investment, sales force ...lobal pharmaceutical industry. Reports,have shown ...address this alarming issue, Eularis announces tod...
..., the leading,provider of databases, software and ...Elan Pharmaceuticals has joined the MetaTox Consor...will be focused on developing,systems biology tool...overy(TM) platform with toxicity ontologies,develo...
Other Medicine News:Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 2Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 3Health News:Evalve(R) Completes $60 Million Series D Financing 2Health News:Evalve(R) Completes $60 Million Series D Financing 3Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 2Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 3Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 2Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 3
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: